NEOS Investment Management LLC Decreases Stock Position in Masimo Co. (NASDAQ:MASI)

NEOS Investment Management LLC decreased its holdings in shares of Masimo Co. (NASDAQ:MASI) by 34.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 9,580 shares of the medical equipment provider’s stock after selling 5,030 shares during the period. NEOS Investment Management LLC’s holdings in Masimo were worth $1,584,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of MASI. Vanguard Group Inc. boosted its stake in Masimo by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 4,586,702 shares of the medical equipment provider’s stock worth $758,182,000 after purchasing an additional 66,215 shares in the last quarter. LPL Financial LLC increased its stake in Masimo by 22.9% during the 4th quarter. LPL Financial LLC now owns 4,310 shares of the medical equipment provider’s stock valued at $712,000 after purchasing an additional 803 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of Masimo in the fourth quarter worth $1,554,000. American Century Companies Inc. lifted its stake in shares of Masimo by 12.2% during the fourth quarter. American Century Companies Inc. now owns 12,659 shares of the medical equipment provider’s stock worth $2,093,000 after buying an additional 1,374 shares during the period. Finally, Virtu Financial LLC purchased a new stake in shares of Masimo during the fourth quarter valued at $244,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Insider Transactions at Masimo

In other Masimo news, Director Craig B. Reynolds sold 2,053 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $166.13, for a total transaction of $341,064.89. Following the transaction, the director now owns 16,581 shares in the company, valued at approximately $2,754,601.53. This represents a 11.02 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Bilal Muhsin sold 30,000 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $167.49, for a total value of $5,024,700.00. Following the completion of the sale, the chief operating officer now owns 24,172 shares of the company’s stock, valued at $4,048,568.28. This trade represents a 55.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 9.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on MASI shares. Wells Fargo & Company lifted their price target on Masimo from $193.00 to $205.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Piper Sandler lifted their target price on Masimo from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a report on Wednesday, February 26th. Finally, Raymond James lifted their price objective on shares of Masimo from $170.00 to $194.00 and gave the company an “outperform” rating in a research note on Friday, December 27th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $194.80.

Masimo Stock Down 2.9 %

Shares of MASI stock opened at $163.55 on Friday. Masimo Co. has a twelve month low of $101.61 and a twelve month high of $194.88. The stock has a market cap of $8.82 billion, a P/E ratio of 112.79 and a beta of 1.04. The stock has a 50 day moving average of $174.79 and a 200 day moving average of $161.39. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50.

Masimo (NASDAQ:MASI) last posted its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.38. The firm had revenue of $600.70 million during the quarter, compared to analysts’ expectations of $593.35 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. As a group, sell-side analysts expect that Masimo Co. will post 4.1 EPS for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.